1-Adamantanecarboxylic acid → HCID 178446105, compound
Reaction equation
[CH3:1][C:2]1[N:3]=[C:4]([NH2:8])[S:5][C:6]=1[CH3:7].Br[CH2:10][C:11]#[C:12][CH2:13][CH3:14].[C:15]12([C:25]([OH:27])=O)[CH2:24][CH:19]3[CH2:20][CH:21]([CH2:23][CH:17]([CH2:18]3)[CH2:16]1)[CH2:22]2>>[CH3:1][C:2]1[N:3]([CH2:10][C:11]#[C:12][CH2:13][CH3:14])/[C:4](=[N:8]/[C:25]([C:15]23[CH2:16][CH:17]4[CH2:18][CH:19]([CH2:20][CH:21]([CH2:23]4)[CH2:22]2)[CH2:24]3)=[O:27])/[S:5][C:6]=1[CH3:7]Participants
4
Procedure
4,5-Dimethylthiazol-2-ylamine, 1-bromo-pent-2-yne and 1-adamantane carboxylic acid were processed according to the method of Example 47 to afford the title compound. 1H NMR (CDCl3, 500 MHz) δ ppm 1.03 (t, J=7.49 Hz, 3H) 1.64-1.75 (m, 6H) 1.84 (d, J=2.50 Hz, 6H) 1.94-2.02 (m, 3H) 2.16 (s, 3H) 2.16-2.22 (m, 2H) 2.28 (s, 3H) 5.00 (t, J=2.18 Hz, 2H); MS (ESI) m/z 357 (M+H)+.
Sources & evidence
- ORD record
- ord-1c619afc45e74bbfab7b7ece2e3521e2
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09006275B2
Reaction notes
Loading…